Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT
All CISA Advisories, CISA, June 18, 2026
Summary
Successful exploitation of these vulnerabilities could allow an attacker to obtain sensitive health-related information and prevent legitimate users from establishing a connection with the device.
The following versions of Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT are affected:
- Blood Glucose Monitoring System (Model No. APG-01 BT) 0x0110_v1.1.0 (CVE-2026-50034, CVE-2026-52866)
| CVSS | Vendor | Equipment | Vulnerabilities |
|---|---|---|---|
| v3 6.5 | Apollo Pharmacy | Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT | Cleartext Transmission of Sensitive Information, Missing Authorization |
Background
- Critical Infrastructure Sectors: Healthcare and Public Health
- Countries/Areas Deployed: India
- Company Headquarters Location: India
Vulnerabilities
CVE-2026-50034
An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.
Affected Products
Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT
Apollo Pharmacy
Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT): 0x0110_v1.1.0
known_affected
Remediations
Mitigation
Apollo Pharmacy did not respond to CISA’s requests to coordinate. Users are encouraged to reach out to Apollo Pharmacy directly for more information:https://www.apollopharmacy.in/contact-us.
https://www.apollopharmacy.in/contact-us
Mitigation
CISA recommends users follow the guidance in the Understanding Bluetooth Technology blog https://www.cisa.gov/news-events/news/understanding-bluetooth-technology.
https://www.cisa.gov/news-events/news/understanding-bluetooth-technology
Relevant CWE: CWE-319 Cleartext Transmission of Sensitive Information
Metrics
| CVSS Version | Base Score | Base Severity | Vector String |
|---|---|---|---|
| 3.1 | 6.5 | MEDIUM | CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N |
| 4.0 | 7.1 | HIGH | CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N |
CVE-2026-52866
An attacker within BLE communication range can monopolize the device’s only available BLE connection slot, preventing legitimate users or applications from establishing a connection.
Affected Products
Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT
Apollo Pharmacy
Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT): 0x0110_v1.1.0
known_affected
Remediations
Mitigation
Apollo Pharmacy did not respond to CISA’s requests to coordinate. Users are encouraged to reach out to Apollo Pharmacy directly for more information:https://www.apollopharmacy.in/contact-us.
https://www.apollopharmacy.in/contact-us
Mitigation
CISA recommends users follow the guidance in the Understanding Bluetooth Technology blog https://www.cisa.gov/news-events/news/understanding-bluetooth-technology.
https://www.cisa.gov/news-events/news/understanding-bluetooth-technology
Relevant CWE: CWE-862 Missing Authorization
Metrics
| CVSS Version | Base Score | Base Severity | Vector String |
|---|---|---|---|
| 3.1 | 6.5 | MEDIUM | CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H |
| 4.0 | 7.1 | HIGH | CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N |
Acknowledgments
- Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA
Legal Notice and Terms of Use
This product is provided subject to this Notification (https://www.cisa.gov/notification) and this Privacy & Use policy (https://www.cisa.gov/privacy-policy).
Recommended Practices
CISA recommends users take defensive measures to minimize the risk of exploitation of these vulnerabilities.
Minimize network exposure for all control system devices and/or systems, ensuring they are not accessible from the internet.
Locate control system networks and remote devices behind firewalls and isolating them from business networks.
When remote access is required, use more secure methods, such as Virtual Private Networks (VPNs), recognizing VPNs may have vulnerabilities and should be updated to the most current version available. Also recognize VPN is only as secure as the connected devices.
CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.
CISA also provides a section for control systems security recommended practices on the ICS webpage on cisa.gov/ics. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
CISA encourages organizations to implement recommended cybersecurity strategies for proactive defense of ICS assets.
Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov/ics in the technical information paper, ICS-TIP-12-146-01B–Targeted Cyber Intrusion Detection and Mitigation Strategies.
Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents.
No known public exploitation specifically targeting these vulnerabilities has been reported to CISA at this time. These vulnerabilities are not exploitable remotely.
Revision History
- Initial Release Date: 2026-06-18
| Date | Revision | Summary |
|---|---|---|
| 2026-06-18 | 1 | Initial Publication |
